SK18802000A3 - SPâSOBY ZNI¦OVANIA HLADÖN HOMOCYSTEÖNU A C-REAKTÖVNEHO PROTEÖNU - Google Patents
SPâSOBY ZNI¦OVANIA HLADÖN HOMOCYSTEÖNU A C-REAKTÖVNEHO PROTEÖNU Download PDFInfo
- Publication number
- SK18802000A3 SK18802000A3 SK1880-2000A SK18802000A SK18802000A3 SK 18802000 A3 SK18802000 A3 SK 18802000A3 SK 18802000 A SK18802000 A SK 18802000A SK 18802000 A3 SK18802000 A3 SK 18802000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- compound
- homocysteine
- reactive protein
- acid addition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8960198P | 1998-06-17 | 1998-06-17 | |
| PCT/US1999/012604 WO1999065306A1 (en) | 1998-06-17 | 1999-06-04 | Methods for reducing levels of homocysteine and c-reactive protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK18802000A3 true SK18802000A3 (sk) | 2001-09-11 |
Family
ID=22218549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1880-2000A SK18802000A3 (sk) | 1998-06-17 | 1999-06-04 | SPâSOBY ZNI¦OVANIA HLADÖN HOMOCYSTEÖNU A C-REAKTÖVNEHO PROTEÖNU |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6353003B1 (ja) |
| EP (1) | EP0966965A1 (ja) |
| JP (1) | JP2002518296A (ja) |
| KR (1) | KR20010052947A (ja) |
| CN (1) | CN1305342A (ja) |
| AU (1) | AU753035B2 (ja) |
| BR (1) | BR9911224A (ja) |
| CA (1) | CA2333384A1 (ja) |
| EA (1) | EA200100049A1 (ja) |
| HR (1) | HRP20000860A2 (ja) |
| HU (1) | HUP0102383A3 (ja) |
| IL (1) | IL138915A0 (ja) |
| NO (1) | NO20006086L (ja) |
| PL (1) | PL344841A1 (ja) |
| SK (1) | SK18802000A3 (ja) |
| TR (1) | TR200003713T2 (ja) |
| WO (1) | WO1999065306A1 (ja) |
| ZA (1) | ZA200005884B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1585507A2 (en) * | 2003-01-06 | 2005-10-19 | Wyeth | The use of estrogen receptor alpha modulators for the treatment of multiphe sclerosis |
| US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| US7196093B2 (en) * | 2003-04-09 | 2007-03-27 | General Atomics | Reversible inhibitors of SAH hydrolase and uses thereof |
| US7868011B2 (en) * | 2003-04-09 | 2011-01-11 | General Atomics | Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus |
| WO2004093882A1 (ja) * | 2003-04-18 | 2004-11-04 | Advanced Medicine Research Institute | 眼に適用する疾患治療剤 |
| US20070003600A1 (en) * | 2003-06-11 | 2007-01-04 | Carolyn Moore | Methods for reducing c-reactive protein |
| TWI386204B (zh) * | 2008-04-10 | 2013-02-21 | Mitsubishi Tanabe Pharma Corp | 高半胱胺酸合成酶抑制劑 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US5075321A (en) | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| TW383306B (en) | 1992-12-22 | 2000-03-01 | Lilly Co Eli | New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol |
| US5482949A (en) | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| US5445941A (en) | 1993-06-21 | 1995-08-29 | Eli Lilly And Company | Method for screening anti-osteoporosis agents |
| US5441947A (en) | 1993-08-25 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting vascular restenosis |
| US5476862A (en) | 1993-12-21 | 1995-12-19 | Eli Lilly And Company | Methods of increasing thrombomodulin expression |
| ES2163425T3 (es) | 1993-12-21 | 2002-02-01 | Lilly Co Eli | Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica. |
| US5441965A (en) | 1993-12-21 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting thrombin |
| US5510357A (en) | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
| JP4111352B2 (ja) | 1996-05-21 | 2008-07-02 | 新日鐵住金ステンレス株式会社 | ステンレス鋼の高清浄化精錬法 |
| US6069175A (en) | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
| US6025373A (en) | 1997-04-22 | 2000-02-15 | Eli Lilly And Company | Methods for reducing fibrinogen |
| US6103740A (en) | 1997-08-21 | 2000-08-15 | Eli Lilly And Company | Methods for lowering platelet counts |
-
1999
- 1999-05-03 US US09/303,618 patent/US6353003B1/en not_active Expired - Fee Related
- 1999-06-04 BR BR9911224-8A patent/BR9911224A/pt not_active IP Right Cessation
- 1999-06-04 TR TR2000/03713T patent/TR200003713T2/xx unknown
- 1999-06-04 CA CA002333384A patent/CA2333384A1/en not_active Abandoned
- 1999-06-04 CN CN99807136A patent/CN1305342A/zh active Pending
- 1999-06-04 KR KR1020007014326A patent/KR20010052947A/ko not_active Application Discontinuation
- 1999-06-04 HU HU0102383A patent/HUP0102383A3/hu unknown
- 1999-06-04 SK SK1880-2000A patent/SK18802000A3/sk unknown
- 1999-06-04 EA EA200100049A patent/EA200100049A1/ru unknown
- 1999-06-04 AU AU48192/99A patent/AU753035B2/en not_active Ceased
- 1999-06-04 IL IL13891599A patent/IL138915A0/xx unknown
- 1999-06-04 EP EP99304364A patent/EP0966965A1/en not_active Withdrawn
- 1999-06-04 WO PCT/US1999/012604 patent/WO1999065306A1/en not_active Application Discontinuation
- 1999-06-04 PL PL99344841A patent/PL344841A1/xx not_active Application Discontinuation
- 1999-06-04 JP JP2000554197A patent/JP2002518296A/ja not_active Withdrawn
-
2000
- 2000-10-20 ZA ZA200005884A patent/ZA200005884B/en unknown
- 2000-11-30 NO NO20006086A patent/NO20006086L/no not_active Application Discontinuation
- 2000-12-14 HR HR20000860A patent/HRP20000860A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL138915A0 (en) | 2001-11-25 |
| US6353003B1 (en) | 2002-03-05 |
| TR200003713T2 (tr) | 2001-04-20 |
| AU4819299A (en) | 2000-01-05 |
| HRP20000860A2 (en) | 2001-10-31 |
| BR9911224A (pt) | 2001-02-20 |
| JP2002518296A (ja) | 2002-06-25 |
| NO20006086D0 (no) | 2000-11-30 |
| WO1999065306A1 (en) | 1999-12-23 |
| PL344841A1 (en) | 2001-11-19 |
| HUP0102383A2 (hu) | 2002-01-28 |
| EP0966965A1 (en) | 1999-12-29 |
| CN1305342A (zh) | 2001-07-25 |
| CA2333384A1 (en) | 1999-12-23 |
| ZA200005884B (en) | 2001-10-22 |
| AU753035B2 (en) | 2002-10-03 |
| NO20006086L (no) | 2000-11-30 |
| EA200100049A1 (ru) | 2001-06-25 |
| KR20010052947A (ko) | 2001-06-25 |
| HUP0102383A3 (en) | 2003-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1465638B1 (en) | Phosphate transport inhibitors | |
| US5747510A (en) | Pharmaceutical unit dosage formulations | |
| CZ288984B6 (cs) | Farmaceutický prostředek k inhibici Alzheimerovy nemoci, ke zvyąování TGF-beta exprese v mozku, k inhibici zánětlivé odezvy spojené s Alzheimerovou nemocí a k inhibici neurotoxicity zprostředkované beta-amyloidním peptidem | |
| WO1995014384A1 (en) | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds | |
| RU2133121C1 (ru) | Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани | |
| KR20110086700A (ko) | 통상의 와파린 요법에 비해 안전성 프로파일이 향상된 다비가트란 에텍실레이트 또는 이의 염을 사용하여 혈전증을 치료하거나 예방하는 방법 | |
| KR20110082564A (ko) | 통상의 와파린 요법에 비해 효능이 향상된 다비가트란 에텍실레이트 또는 이의 염을 사용하여 혈전증을 치료하거나 예방하는 방법 | |
| PL193405B1 (pl) | Zastosowanie wybiórczych inhibitorów pośrednich czynnika Xa w połączeniu z substancją hamującą agregację płytek krwi do wytwarzania leku do leczenia zakrzepowo-zatorowych chorób tętnic oraz preparatyfarmaceutyczne | |
| CZ320694A3 (en) | Pharmaceutical preparation for inhibiting autoimmune diseases | |
| RU2138261C1 (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования расстройств цнс у женщин в постменопаузе | |
| SK18802000A3 (sk) | SPâSOBY ZNI¦OVANIA HLADÖN HOMOCYSTEÖNU A C-REAKTÖVNEHO PROTEÖNU | |
| CZ322194A3 (en) | Pharmaceutical preparation for inhibiting turner syndrome | |
| KR20000015805A (ko) | 일산화질소 합성을 증가시키는 방법 | |
| CZ20004701A3 (cs) | Způsoby snižování hladin homocysteinu a Creaktivního proteinu | |
| EA001003B1 (ru) | Способ ингибирования ингибитора 1 активатора плазминогена | |
| JPH07188010A (ja) | アミロイド形成タンパクの作用を抑制するための医薬組成物 | |
| SK18792000A3 (sk) | Spôsoby zvýšenia hladín acetylcholínu | |
| JP2001515015A (ja) | 血小板数を減少させる方法 | |
| SK18812000A3 (sk) | Spôsoby zvyšovania hladín acetylcholínu | |
| MXPA00011283A (en) | Methods for reducing levels of homocysteine and c-reactive protein | |
| JP5559696B2 (ja) | 糖尿病性腎症の治療剤 | |
| CZ2003476A3 (cs) | Farmaceutický prostředek obsahující metformin a derivát typu 5-fenoxyalkyl-2,4-thiazolidindionu | |
| RU2176503C2 (ru) | Способы снижения уровней кальция в сыворотке | |
| EA043888B1 (ru) | Лекарственное средство, содержащее комбинацию сепетапроста и ингибитора rho-ассоциированной протеинкиназы, содержащей суперспираль | |
| CZ20004699A3 (cs) | Způsoby zvyšování hladiny acetylcholinu |